Optimal Erythrocyte Ribavirin Level to Reduce the Risk of Anemia and Obtain an Early Virological Response in Patients with Chronic Hepatitis C Caused by Genotype 1b Infection

Figure 3

Comparison of 4-week hemoglobin reduction rate from the baseline of the patients with 2-week erythrocyte phosphorylated ribavirin concentration(<800 𝜇M) to 4-week hemoglobin reduction rate from the baseline of the patients with 2-week erythrocyte phosphorylated ribavirin concentration(800 𝜇M ≦).